Cough Syrup Market Size, Share, Trends, Growth 2024-2032

The global cyclophosphamide drug market is anticipated to witness substantial growth over the forecast period of 2024-2032. Cyclophosphamide, a medication primarily used for chemotherapy, is expected to gain traction due to the rising prevalence of cancer worldwide. The market was valued at USD 827.91 million in 2023 and is projected to grow at a CAGR of X% during the forecast period, reaching a value of USD Y million by 2032. Factors such as the increasing incidence of cancer, advancements in drug delivery technologies, and the development of novel formulations are expected to drive market growth. Additionally, the growing focus on personalized medicine and targeted therapies is anticipated to further fuel market expansion.